FDA Grants Abbreviated Approval for Metformin Hydrochloride by Sunshine
The FDA has granted abbreviated approval (AP) for the ANDA208999 application for Metformin Hydrochloride submitted by Sunshine.
Asset / Drug
Drug and asset intelligence for Sunshine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.